GRM3 and central nervous system cancer: In addition, Khan and colleagues have demonstrated that treating mGluR3-expressing U87 glioma cells with riluzole increased DNA damage and the cytotoxicity of glioma cells both in vitro and in vivo; furthermore, treatment with riluzole sensitizes U87 cells to γ-radiation [119].